Clinical Trial Update: An Investigational Scan (64Cu-Labeled M5A Antibody) in Combination With SOC Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer [EARLY_Phase 1]

View source ↗

Summary

Update on an early-phase trial of a copper-64 labeled M5A antibody in combination with standard chemotherapy and radiotherapy for locally advanced rectal cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• 64Cu-labeled M5A antibody (M5A antibody)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Locally Advanced Rectal Carcinoma, Stage III Rectal Cancer AJCC v8 | EARLY_Phase 1 | Status: RECRUITING